Twist Bioscience

Company

Investment-firm

Last deal

$250.M

Amount

Post-IPO Equity

Stage

10.02.2022

Date

10

all rounds

$553.1M

Total amount

General

About Company
Twist Bioscience is a synthetic biology company that develops a silicon-based manufacturing process for the production of synthetic DNA.

Industry

Sector :

Subsector :

Keywords :

Also Known As

Twist

founded date

01.01.2013

Number of employees

Company Type

For Profit

Last funding type

Post-IPO Equity

IPO status

Private

Description

Twist Bioscience serves Life Science researchers in diverse fields such as medicine, agriculture, industrial chemicals, and data storage. Their innovative DNA Synthesis Platform provides precision at a scale that is otherwise unavailable, enabling cost-effective, rapid, precise, high-throughput DNA synthesis and sequencing. They offer both the quality and quantity researchers need to rapidly realize opportunities ahead.
Contacts